Show simple item record

dc.contributor.authorGören Şahin, Deniz
dc.contributor.authorÖzçelik, Nurcan
dc.contributor.authorKurt Yıldırım, Burcu
dc.contributor.authorHindilerden, Fehmi
dc.contributor.authorGüvenç, Serkan
dc.contributor.authorSami Göksoy, Hasan
dc.contributor.authorReyhan Küçükkaya, Diz
dc.contributor.authorTülay Özçelik, Emine
dc.date.accessioned2021-12-21T08:31:14Z
dc.date.available2021-12-21T08:31:14Z
dc.date.issued2020
dc.identifier.issn1016-9113
dc.identifier.issn2147-6500
dc.identifier.urihttps://app.trdizin.gov.tr/makale/TXpnMk5qZzVPUT09/miyelofibrozisli-olgularda-allojenik-kok-hucre-nakil-sonuclarimiz-tek-merkezli-retrospektif-bir-analiz
dc.identifier.urihttp://dspace.yeniyuzyil.edu.tr:8080/xmlui/handle/20.500.12629/645
dc.description.abstractAmaç: Primer miyelofibrozis (PMF), kronik miyeloproliferasyon, atipik megakaryositik hiperplazi vekem k l ğ f broz s le karakter ze klonal b r kök hücre hastalığıdır. Bu hastalarda günümüzde halengöster leb lm ş tek şifa sağlayıcı tedavi seçeneği olan all
dc.description.abstractAim: Primary myelofibrosis (PMF) is a clonal stem cell disease characterized by chronic myeloproliferation, atypical megakaryocytic hyperplasia and bone marrow fibrosis. Allogeneic stem cell transplantation, which is the only curative treatment option,
dc.language.isoTurkish
dc.titleMiyelofibrozisli olgularda allojenik kök hücre nakil sonuçlarımız: tek merkezli, retrospektif bir analiz
dc.title.alternativeAllogeneic stem cell transplantation in patients with myelofibrosis: single center, retrospective study
dc.relation.journalEge Tıp Dergisi
dc.identifier.issue2
dc.identifier.startpage109
dc.identifier.endpage112
dc.identifier.volume59
dc.relation.issue2
dc.relation.volume59


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record